In silico design and analysis of a new hyperglycosylated analog of erythropoietin to improve drug efficacy

BACKGROUND: The enhancement of glycosylation by applying glycoengineering approaches has become widely used to boost properties for protein therapeutics. The objective of this work was to engineer a new hyperglycosylated analog of erythropoietin (EPO) with appropriately targeted N-linked carbohydrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kianmehr, Anvarsadat, Mohammadi, Hamid Shahbaz, Shokrgozar, Mohammad Ali, Omidinia, Eskandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549927/
https://www.ncbi.nlm.nih.gov/pubmed/26322290
http://dx.doi.org/10.4103/2277-9175.161548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549927/
https://www.ncbi.nlm.nih.gov/pubmed/26322290
http://dx.doi.org/10.4103/2277-9175.161548

Ejemplares similares